Emergence of RAS mutations in patients with metastatic colorectal cancer receiving cetuximab-based treatment

被引：0
|
作者：
Wang, Jaw-Yuan
Tsai, Hsiang-Lin
Sung, Yung-Chuan
机构：
[1] Kaohsiung Med Univ, Kaohsiung Med Univ Hosp, Kaohsiung, Taiwan
[2] Kaohsiung Med Univ, Chung Ho Mem Hosp, Dept Surg, Div Colorectal Surg, Kaohsiung, Taiwan
[3] Cathay Gen Hosp, Div Hematol Oncol, Dept Internal Med, Taipei, Taiwan
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2020年 / 38卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
208
引用
收藏
页数：2
相关论文
共 50 条
  • [21] Impact of Cetuximab-based Therapy and KRas Genotypes in Japanese Patients With Chemotherapy-refractory Metastatic Colorectal Cancer
    Kohnoe, S.
    Saeki, H.
    Emi, Y.
    Ando, K.
    Ohga, T.
    Oki, E.
    Ikeda, T.
    Tsujitani, S.
    Kakeji, Y.
    Maehara, Y.
    EUROPEAN JOURNAL OF CANCER, 2011, 47 : S429 - S429
  • [22] Role of EGFR, DCC and K-RAS mutations in metastatic colorectal cancer (mCRC) patients treated with cetuximab
    Mancuso, A.
    Leone, A.
    Cerbone, L.
    Zivi, A.
    Squilloni, E.
    Bertagnolio, F.
    Caristo, R.
    Gasbarra, R.
    Roberto, P.
    Sternberg, C.
    ANNALS OF ONCOLOGY, 2008, 19 : 39 - 39
  • [23] FOLFOX4 plus cetuximab treatment and RAS mutations in colorectal cancer
    Bokemeyer, C.
    Koehne, C. -H.
    Ciardiello, F.
    Lenz, H. -J.
    Heinemann, V.
    Klinkhardt, U.
    Beier, F.
    Duecker, K.
    van Krieken, J. H.
    Tejpar, S.
    EUROPEAN JOURNAL OF CANCER, 2015, 51 (10) : 1243 - 1252
  • [24] Fluorouracil, Leucovorin, and Irinotecan Plus Cetuximab Treatment and RAS Mutations in Colorectal Cancer
    Van Cutsem, Eric
    Lenz, Heinz-Josef
    Koehne, Claus-Henning
    Heinemann, Volker
    Tejpar, Sabine
    Melezinek, Ivan
    Beier, Frank
    Stroh, Christopher
    Rougier, Philippe
    van Krieken, J. Han
    Ciardiello, Fortunato
    JOURNAL OF CLINICAL ONCOLOGY, 2015, 33 (07) : 692 - 700
  • [25] CETUXIMAB-BASED REGIMENS IN METASTATIC COLORECTAL CANCER (MCRC): ROLE OF PTEN EXPRESSION IN CLINICAL OUTCOME
    Bravaccini, Sara
    Valgiusti, Martina
    Ulivi, Paola
    Frassineti, Giovanni Luca
    Capelli, Laura
    Moscati, Roberta
    Saragoni, Luca
    Surace, Giovanna Chiara
    Scarpi, Emanuela
    Passardi, Alessandro
    ANNALS OF ONCOLOGY, 2011, 22 : v106 - v106
  • [26] Polymorphisms in toll-like receptor (TLR) genes in the prediction of outcome for cetuximab-based treatment in patients with metastatic colorectal cancer (mCRC).
    Okazaki, Satoshi
    Stintzing, Sebastian
    Sunakawa, Yu
    Cao, Shu
    Zhang, Wu
    Yang, Dongyun
    Ning, Yan
    Berger, Martin D.
    West, Jordan David
    Gopez, Roel
    Miyamoto, Yuji
    Suenaga, Mitsukuni
    Barzi, SchirripatAfsaneh
    Hanna, Diana L.
    Tsuji, Akihito
    Ichikawa, Wataru
    Heinemann, Volker
    DePaolo, William
    Lenz, Heinz-Josef
    JOURNAL OF CLINICAL ONCOLOGY, 2016, 34 (15)
  • [27] Immune-modulating effect of the cetuximab-based chemoimmunotherapy in patients with colorectal cancer
    Holubec, Lubos
    Polivka, Jiri
    Liska, Vaclav
    Safanda, Martin
    INTERNATIONAL JOURNAL OF MOLECULAR MEDICINE, 2016, 38 : S75 - S75
  • [28] Emergence of Multiple EGFR Extracellular Mutations during Cetuximab Treatment in Colorectal Cancer
    Arena, Sabrina
    Bellosillo, Beatriz
    Siravegna, Giulia
    Martinez, Alejandro
    Canadas, Israel
    Lazzari, Luca
    Ferruz, Noelia
    Russo, Mariangela
    Misale, Sandra
    Gonzalez, Iria
    Iglesias, Mar
    Gavilan, Elena
    Corti, Giorgio
    Hobor, Sebastijan
    Crisafulli, Giovanni
    Salido, Marta
    Sanchez, Juan
    Dalmases, Alba
    Bellmunt, Joaquim
    De Fabritiis, Gianni
    Rovira, Ana
    Di Nicolantonio, Federica
    Albanell, Joan
    Bardelli, Alberto
    Montagut, Clara
    CLINICAL CANCER RESEARCH, 2015, 21 (09) : 2157 - 2166
  • [29] Emergence of multiple EGFR extracellular mutations during cetuximab treatment in colorectal cancer
    Lazzari, Luca
    Arena, Sabrina
    Bellosillo, Beatriz
    Siravegna, Giulia
    Martinez, Alejandro
    Canadas, Israel
    Ferruz, Noelia
    Russo, Mariangela
    Misale, Sandra
    Gonzalez, Iria
    Iglesias, Mar
    Gavilan, Elena
    Corti, Giorgio
    Hobor, Sebastijan
    Crisafulli, Giovanni
    Salido, Marta
    Sanchez, Juan
    Dalmases, Alba
    Bellmunt, Joaquim
    De Fabritiis, Gianni
    Rovira, Ana
    Di Nicolantonio, Federica
    Albanell, Joan
    Bardelli, Alberto
    Montagut, Clara
    CANCER RESEARCH, 2015, 75
  • [30] SMAD4 and NF1 mutations as potential biomarkers for poor prognosis to cetuximab-based therapy in Chinese metastatic colorectal cancer patients
    Zhu Mei
    Yang W. Shao
    Peinan Lin
    Xiaomin Cai
    Biao Wang
    Yan Ding
    Xiangyuan Ma
    Xue Wu
    Yewei Xia
    Dongqin Zhu
    Yongqian Shu
    Zan Fu
    Yanhong Gu
    BMC Cancer, 18
12345